Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Share-based Compensation (2016 - 2025)

Surgery Partners' Share-based Compensation history spans 12 years, with the latest figure at -$2.2 million for Q4 2025.

  • For Q4 2025, Share-based Compensation fell 135.48% year-over-year to -$2.2 million; the TTM value through Dec 2025 reached $14.8 million, down 55.56%, while the annual FY2025 figure was $14.8 million, 55.56% down from the prior year.
  • Share-based Compensation for Q4 2025 was -$2.2 million at Surgery Partners, down from $2.6 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $15.1 million in Q2 2024 and bottomed at -$2.2 million in Q4 2025.
  • The 5-year median for Share-based Compensation is $4.6 million (2023), against an average of $5.1 million.
  • The largest annual shift saw Share-based Compensation skyrocketed 228.26% in 2024 before it plummeted 135.48% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $4.0 million in 2021, then soared by 35.0% to $5.4 million in 2022, then decreased by 16.67% to $4.5 million in 2023, then soared by 37.78% to $6.2 million in 2024, then plummeted by 135.48% to -$2.2 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Share-based Compensation are -$2.2 million (Q4 2025), $2.6 million (Q3 2025), and $6.8 million (Q2 2025).